Magnesium Complex
Magnesium Complex, licence 80147342: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Complexe Magnésium, Complexe de magnésium 250 mg, Magnesium 250 mg, Magnesium Complex 250 mg, Magnésium 250 mg
- Licence holder
- Laboratoire LSL Inc.
- NPN or DIN-HM
- 80147342
- Status
- Active licence
- Licence date
- 16 February 2026
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Lactate de magnésium | 250.0 mg | 250,000 µg |
| Magnésium Source : Oxyde de magnésium | 250.0 mg | 250,000 µg |
| Magnésium Source : Gluconate de magnésium | 250.0 mg | 250,000 µg |
| Magnésium Source : Citrate de magnésium | 250.0 mg | 250,000 µg |
Non-medicinal ingredients
Cellulose microcristalline, Croscarmellose de sodium, Poly(alcool vinylique), Talc, Poly(éthylène glycol), Stéarate de magnésium, Dioxyde de silicium colloïdal
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 1.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones/(and) teeth. Helps to maintain/support normal muscle function, including the heart muscle.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80147342
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.